French start-ups Jimmy Energy and Calogena have secured €180m to advance small modular reactor designs under the France 2030 ...

Abstract: In the manufacturing industry, the Facility Layout Problem (FLP) focuses on determining the optimal arrangement of facilities to minimize production costs, primarily by reducing the total ...

Converting wave motion into electricity holds enormous potential as a renewable energy source, but a lack of standardized prototyping is holding back technological development. A research team led by ...

NANO Nuclear Energy is a New York company led by CEO James Walker. The company designs advanced and portable reactors, such as the Zeus microreactor. Walker told The Epoch Times that several factors ...

Small and midsize businesses are entering 2026 with a renewed sense of optimism, but what stands out in Citizens’ Q1 2026 Business Pulse survey is why they’re optimistic. The data tells a story that ...

Abstract: A fast infrared small target recognition method based on FPGA is introduced. By utilizing the advantages of FPGA parallel pipeline data processing, this method achieves fast and accurate ...

SPDR S&P 600 Small Cap Growth ETF earns a 'buy' rating due to its components' strong and achievable earnings growth rate, compelling valuations, and double-digit earnings surprises. These attractive ...

Columbia, S.C. — Georgia track & field closes out the remainder of the indoor regular season sending a small distance squad to South Carolina's USC Invite held at the Sheila & Morris Cregger Indoor ...

Earlier this month, US President Donald Trump signed into effect the re-authorization of the US Food and Drug Administration’s (FDA) Priority Review Voucher (PRV) program after the associated bill ...

WASHINGTON, Feb 17 (Reuters) - The U.S. Federal Reserve could approve "several more" interest rate cuts this year if inflation resumes a decline to the central bank's 2% target, Chicago Fed President ...

Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...